diclofenac has been researched along with Hypersensitivity in 3 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Hypersensitivity: Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Nunes, IKDC | 1 |
de Souza, ET | 1 |
Martins, IRR | 1 |
Barbosa, G | 1 |
Moraes Junior, MO | 1 |
Medeiros, MM | 1 |
Silva, SWD | 1 |
Balliano, TL | 1 |
da Silva, BA | 1 |
Silva, PMR | 1 |
Carvalho, VF | 1 |
Martins, MA | 1 |
Lima, LM | 1 |
Malbrán, A | 1 |
Yeyati, E | 1 |
Rey, GL | 1 |
Galassi, N | 1 |
Hirasawa, N | 1 |
Ohuchi, K | 1 |
Sugio, K | 1 |
Tsurufuji, S | 1 |
Watanabe, M | 1 |
Yoshino, S | 1 |
3 other studies available for diclofenac and Hypersensitivity
Article | Year |
---|---|
Discovery of sulfonyl hydrazone derivative as a new selective PDE4A and PDE4D inhibitor by lead-optimization approach on the prototype LASSBio-448: In vitro and in vivo preclinical studies.
Topics: Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Design; Enzyme Inhibitors; H | 2020 |
Diclofenac induces basophil degranulation without increasing CD63 expression in sensitive patients.
Topics: Allergens; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; Basophil Degranulation Te | 2007 |
Vascular permeability responses and the role of prostaglandin E2 in an experimental allergic inflammation of air pouch type in rats.
Topics: Animals; Capillary Permeability; Diclofenac; Dinoprostone; Hypersensitivity; Indomethacin; Inflammat | 1986 |